Description
Surgical–Pathological Staging
Pathologic staging reflexes the extension of tumor and is important to determine the prognosis and plan treatment. Surgical staging includes hysterectomy, bilateral salpingo-oophorectomy, and assessment of the pelvic and paraaortic lymph nodes. Pelvic washings are no longer required for surgical staging; however, the presence of cancer cells in the peritoneal cavity is a poor prognostic factor (Harouny 1988; Grimshaw et al. 1990; Kennedy et al. 1987).
The two systems used for staging of both endometrial cancer and uterine sarcoma are the American Joint Committee on Cancer TNM (AJCC) staging system and the Union for International Cancer Control (UICC) with the parallel staging system formatted by FIGO (International Federation of Gynecology and Obstetrics) system (Tables 1 and 2). According to International Federation of Gynecology and Obstetrics (FIGO) Grading System, this system applies only to endometrioid and mucinous carcinoma, not serous,...
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References and Further Reading
Abeler, V. M., & Kjorstad, K. E. (1990). Serous papillary carcinoma of the endometrium: A histopathological study of 22 cases. Gynecologic Oncology, 39, 266–271.
Abu-Rustum, N. R. (2014). Sentinel lymph node mapping for endometrial cancer: A modern approach to surgical staging. Journal of the National Comprehensive Cancer Network, 2014(12), 288–297.
Al Kushi, A., et al. (2002). Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium. Modern Pathology, 15, 365–371.
Ambros, R. A., & Kurman, R. J. (1992a). Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer, 69, 1424–1431.
Ambros, R. A., & Kurman, R. J. (1992b). Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion. Gynecologic Oncology, 45, 235–239.
Amin, M. B., Edge, S. B., Greene, F. L., et al. (Eds.). (2017). AJCC cancer staging manual (8th ed.). New York: Springer.
Boronow, R. C., et al. (1984). Surgical staging in endometrial cancer: Clinical-pathologic findings of a prospective study. Obstetrics and Gynecology, 63, 825–832.
Bosse, T. (2015). Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer. European Journal of Cancer, 51, 1742–1750.
Brierley, J. D., Gospodarowicz, M. K., Wittekind, C., et al. (Eds.). (2016). TNM classification of malignant tumours (8th ed.). Oxford, UK: Wiley.
Chan, J. K., & Kapp, D. S. (2007). Role of complete lymphadenectomy in endometrioid uterine cancer. The Lancet Oncology, 8, 831–841.
Chi, D. S., et al. (2008). The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. International Journal of Gynecological Cancer, 18, 269–273.
Christopherson, W. M., Connelly, P. J., & Alberhasky, R. C. (1983). Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and Stage I disease. Cancer, 51, 1705–1709.
Eifel, P. J., et al. (1983). Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: Treatment comparisons. Cancer, 52, 1026–1031.
Euscher, E., Sui, D., Soliman, P., et al. (2018). Ultrastaging of sentinel lymph nodes in endometrial carcinoma according to use of 2 different methods. International Journal of Gynecological Pathology, 37, 242–251. 97.
Fersis, N., et al. (2004). Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer. European Journal of Gynaecological Oncology, 25, 339–342.
Gal, D., et al. (1991). Lymphvascular space involvement – A prognostic indicator in endometrial adenocarcinoma. Gynecologic Oncology, 42, 142–145. 139.
Gambrell, R. D., Jr., Bagnell, C. A., & Greenblatt, R. B. (1983). Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: Review. American Journal of Obstetrics and Gynecology, 146, 696–707.
Grimshaw, R. N., et al. (1990). Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecologic Oncology, 36, 97–100.
Hanson, M. B., et al. (1985). The prognostic significance of lymph- vascular space invasion in stage I endometrial cancer. Cancer, 55, 1753–1757.
Harouny, V. R., et al. (1988). The importance of peritoneal cytology in endometrial carcinoma. Obstetrics and Gynecology, 72, 394–398.
Kennedy, A. W., et al. (1987). Experience with pelvic washings in stage I and II endometrial carcinoma. Gynecologic Oncology, 28, 50–60.
Lee, K. R., Vacek, P. M., & Belinson, J. L. (1994). Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma. Gynecologic Oncology, 54, 10–18.
Meis, J. M., & Lawrence, W. D. (1990). The immunohistochemical profile of malignant mixed mullerian tumor. Overlap with endometrial adenocarcinoma. American Journal of Clinical Pathology, 94, 1–7.
Moatasim, A., et al. (2021). Assessment of lymphovascular invasion in early stage endometrial carcinoma -a retrospective study. Surgical and Experimental Pathology, 4, 9.
Morrow, C. P., et al. (1991). Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecologic Oncology, 40, 55–65.
Nofech-Mozes, S., et al. (2008). Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma. American Journal of Clinical Pathology, 129, 912–917.
Raza Mirza, M., Koskas, M., & Creutzberg, C. L. (2018). FIGO cancer report. Cancer of the corpus uteri. International Journal of Gynecology & Obstetrics, 143(Suppl 2), 37–50.
Schwab, K. V., et al. (2009). Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma. Gynecologic Oncology, 112, 146–149.
Sivridis, E., Buckley, C. H., & Fox, H. (1987). The prognostic significance of lymphatic vascular space invasion in endometrial adenocarcinoma. British Journal of Obstetrics and Gynaecology, 94, 991–994.
Tornos, C., et al. (1992). Aggressive stage I grade 1 endometrial carcinoma. Cancer, 70, 790–798.
Zaino, R. J., et al. (1996). Pathologic models to predict outcome for women with endometrial adenocarcinoma: The importance of the distinction between surgical stage and clinical stage – A Gynecologic Oncology Group study. Cancer, 77, 1115–1121.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Ali-Fehmi, R., Kheil, M., Almohsen, N.A. (2023). TNM/FIGO Classification, Pathology of the Uterine Corpus. In: Stolnicu, S., Ali-Fehmi, R. (eds) Gynecologic Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-97378-0_5623
Download citation
DOI: https://doi.org/10.1007/978-3-030-97378-0_5623
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-97377-3
Online ISBN: 978-3-030-97378-0
eBook Packages: MedicineReference Module Medicine